secwatch.observer — SEC 8-K summary
======================================

Issuer:     Progyny, Inc. (PGNY)
CIK:        0001551306
Form:       8-K
Filed at:   2023-05-08T23:59:59+00:00
Accession:  0001551306-23-000045
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Progyny Q1 revenue $258.4M (+50% YoY); raises FY2023 guidance
-------------------------------------------------------------

- Net income $17.7M ($0.18 diluted EPS) vs $5.0M ($0.05) in Q1 2022.
- Adjusted EBITDA $46.4M (+87% YoY); margin expanded 350 bps to 17.9%.
- FY2023 revenue guidance raised to $1.04-1.065B from prior range.
- Clients grew to 379 (from 264) and covered lives to 5.34M (+36% YoY).
- Fertility revenue $157.1M (+42%); pharmacy revenue $101.2M (+65%).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1551306/000155130623000045/0001551306-23-000045-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1551306/000155130623000045/pgny-20230508.htm
  HTML page:      https://secwatch.observer/filing/0001551306-23-000045

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer